Clearer Skin Starts With This 3-In-1 Cream

Enjoy clear, radiant skin with our prescription-strength compounded topical cream, designed to reduce redness and inflammation caused by parasites, bacteria, and inflammatory pathways such as rosacea.

Dermatologist-Formulated Triple Action

This topical treatment combines three FDA-approved ingredients:

• Azelaic Acid: Treats acne by unclogging pores, calming inflammation, and reducing redness. Fades post-acne marks and evens skin tone. Has antioxidant properties and is gentle for sensitive skin. ⁽¹⁾
• Ivermectin: Calms irritations, targets parasites, and promotes recovery of inflamed skin. FDA-approved for inflammatory lesions of rosacea. Reduces redness, swelling, and kills Demodex mites contributing to skin inflammation. ⁽²⁾
• Metronidazole: Controls bacterial imbalance, eases redness, and treats moderate to severe rosacea by improving inflammatory lesions and erythema. ⁽³⁾

Triple-Action Synergy

Azelaic Acid reduces inflammation and bacteria, Ivermectin targets parasites, and Metronidazole fights bacterial infections. This doctor-formulated cream combats inflammation, parasites, and bacteria, offering FDA-approved relief for patients with underlying causes of skin redness and rosacea-prone skin.

Relieves Symptoms Including:

• Redness
• Bumps
• Irritation from inflammatory lesions, wounds, or staph

It can take a few weeks to see results. Use only as directed. Avoid direct sunlight and use moisturizer and sunscreen while using.

Cautions

• If the medication gets into your eyes, nose, or mouth, rinse thoroughly with water.
• Do not use with other topical preparations containing sulfur, resorcinol, or salicylic acid, as this may increase side effects.
• If skin irritation occurs, reduce frequency; if irritation persists, stop use and contact your physician or dermatologist.

HSA & FSA Eligible through Wellness Pay

References

1. Sauer N, Oślizło M, Brzostek M, et al. The multiple uses of azelaic acid in dermatology: mechanism of action, preparations, and potential therapeutic applications. Postepy Dermatol Alergol. 2023 Dec;40(6):716-724. doi: 10.5114/ada.2023.133955. PMID: 38282869; PMCID: PMC10809820.
2. Iver Cardwell LA, Alinia H, Moradi Tuchayi S, Feldman SR. New developments in the treatment of rosacea - role of once-daily ivermectin cream. Clin Cosmet Investig Dermatol. 2016 Mar 18;9:71-7. doi: 10.2147/CCID.S98091. PMID: 27051311; PMCID: PMC4807898.
3. McClellan KJ, Noble S. Topical metronidazole. A review of its use in rosacea. Am J Clin Dermatol. 2000 May-Jun;1(3):191-9. doi: 10.2165/00128071-200001030-00007. PMID: 11702300.

Written by Brooke Lounsbury